Top Page
Siix Corporation
(7613)
Siix Corporation (7613) vs. S&P 500 (SPY)
Siix Corporation Business Overview & Revenue Model
Siix Corporation Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 302.31B | 309.77B | 277.03B | 226.83B | 181.60B | Gross Profit |
| 28.61B | 30.85B | 25.79B | 20.12B | 16.15B | EBIT |
| 8.56B | 12.25B | 8.93B | 4.95B | 4.45B | EBITDA |
| 18.34B | 21.18B | 16.64B | 11.09B | 10.50B | Net Income Common Stockholders |
| 3.75B | 8.19B | 4.73B | 4.56B | 1.72B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 22.82B | 18.24B | 13.79B | 9.48B | 23.13B | Total Assets |
| 217.48B | 216.84B | 205.17B | 169.92B | 144.44B | Total Debt |
| 52.87B | 60.24B | 61.26B | 50.01B | 45.87B | Net Debt |
| 30.05B | 42.00B | 47.47B | 40.52B | 22.74B | Total Liabilities |
| 116.45B | 127.29B | 127.78B | 103.55B | 87.94B | Stockholders Equity |
| 100.49B | 89.10B | 76.96B | 65.96B | 56.14B |
| Cash Flow | Free Cash Flow | |||
| 16.62B | 9.47B | -3.54B | -16.24B | 7.14B | Operating Cash Flow |
| 23.10B | 19.80B | 5.57B | -8.11B | 13.28B | Investing Cash Flow |
| -9.09B | -10.39B | -8.89B | -7.76B | -6.03B | Financing Cash Flow |
| -12.32B | -5.99B | 6.68B | 869.00M | 1.29B |
Siix Corporation Technical Analysis
Siix Corporation Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥2.68T | 15.81 | 1.94% | 4.80% | 34.01% | ||
77 Outperform | $16.77T | 27.44 | 10.50% | 1.06% | 0.56% | 5.32% | |
73 Outperform | ¥5.80T | 26.08 | 11.70% | 0.85% | -5.48% | -11.96% | |
73 Outperform | $289.47B | 7.59 | 9.28% | 4.10% | 2.73% | ― | |
70 Outperform | $3.94T | 11.82 | 7.23% | 2.19% | 1.72% | -33.60% | |
68 Neutral | ¥50.19B | 13.32 | 4.52% | -2.41% | -54.06% | ||
60 Neutral | $10.94B | 10.48 | -7.04% | 2.99% | 7.55% | -12.20% |
Siix Corporation Corporate Events
Siix Corporation has completed the payment procedures for the disposal of treasury stock as restricted stock-based compensation, a move initially resolved at a Board of Directors meeting in March 2025. This disposal involved 13,301 shares of common stock, valued at 1,113 yen per share, and was allocated to four directors and three executive officers, potentially impacting the company’s executive compensation structure and aligning management interests with shareholder value.
Siix Corporation has announced a resolution to dispose of treasury stock as restricted stock-based compensation for its directors and executive officers. This move aims to align the interests of its leadership with shareholders by tying compensation to stock performance, thereby motivating directors to enhance corporate value. The initiative reflects the company’s strategy to strengthen its governance and attract diverse talent by revising remuneration structures.
SIIX Corporation announced that it maintains a 22.96% voting rights relationship with SAKATA INX Corporation, an affiliated company, but operates independently in different business domains. The company assures stakeholders of its independent governance and lack of significant business transactions with SAKATA INX, reinforcing its strategic autonomy and operational independence.
Siix Corporation announced changes to its Nomination and Compensation Advisory Committee following the passing of Chairman Shiro Murai. Shinsuke Takatani, an independent outside director, has been appointed as the new chairman, while Kazuya Hiraoka will join as a committee member. These changes aim to maintain the committee’s functionality and ensure continued governance and strategic oversight.
SIIX Corporation announced the passing of its CEO & Chairman, Mr. Shiro Murai, who had been with the company since 1992 and served as CEO since 2003. Despite his passing, the company will maintain the required number of directors as per its Articles of Incorporation, ensuring continuity in its operations.
Siix Corporation announced its consolidated financial results for the fiscal year ended December 31, 2024, reporting a decline in net sales and profits compared to the previous year. Despite a challenging year with decreased revenues, the company saw an increase in comprehensive income and maintained a strong capital adequacy ratio, indicating a stable financial position. The results also highlighted strategic changes with the inclusion of Renzoku Biologics Inc. into its scope of consolidation, signaling potential growth and diversification opportunities. The announcement provides insights into Siix’s ongoing financial health and strategic adjustments, which are critical for shareholders and stakeholders to consider.
Siix Corporation reported a decline in financial performance for the fiscal year ending December 2024, with net sales decreasing by 2.4% and operating profit dropping by 30.2%. Despite a slight increase in comprehensive income, the company’s return on equity and profit ratios have weakened, impacting its profitability. The company’s financial position showed stability with a slight increase in total assets and a stronger capital adequacy ratio. However, cash flows from operating activities improved, indicating better operational efficiency and liquidity management.